SZodixStudyAcademic Library
DashboardShelvesOpen accessMy libraryInboxNotesWriteLearnAlerts
More
Ask your libraryNotificationsQuick citeReview
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
12 references·16 citing·42 second hop
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder (2005)N-acetylcysteine augmentation in serotoni…Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder (2006)Glutamate-modulating drugs as…Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial (2005)Riluzole Augmentation in Trea…Glutamatergic Dysfunction in OCD (2005)Glutamatergic Dysfunction in …Reduced Anterior Cingulate Glutamatergic Concentrations in Childhood OCD and Major Depression Versus Healthy Controls (2004)Reduced Anterior Cingulate Gl…Obsessive–Compulsive Disorder (2004)Obsessive–Compulsive DisorderAssociation of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study (2004)Association of a glutamate (N…Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues (2003)Neurosurgery for intractable …Treatment non-response in OCD: methodological issues and operational definitions (2002)Treatment non-response in OCD…Symptom Stability in Adult Obsessive-Compulsive Disorder: Data From a Naturalistic Two-Year Follow-Up Study (2002)Symptom Stability in Adult Ob…FUNCTIONAL NEUROIMAGING AND THE NEUROANATOMY OF OBSESSIVE-COMPULSIVE DISORDER (2000)FUNCTIONAL NEUROIMAGING AND T…Decrease in Caudate Glutamatergic Concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine (2000)Decrease in Caudate Glutamate…Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet (1997)Structured clinical interview…Treatment-resistant OCD: Pharmacotherapies in adults (2022)Treatment-resistant OCD: Phar…Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders (2020)Clinical advances in obsessiv…N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial (2016)N-acetylcysteine augmentation…N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review (2015)N-Acetyl Cysteine in the Trea…LONG-TERM OUTCOME IN ADULTS WITH OBSESSIVE-COMPULSIVE DISORDER (2013)LONG-TERM OUTCOME IN ADULTS W…Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study (2012)Memantine add-on in moderate …Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder (2012)Effects of Ketamine in Treatm…Neurobiology of obsessive–compulsive disorder: insights into neural circuitry dysfunction through mouse genetics (2011)Neurobiology of obsessive–com…Drug treatment of obsessive-compulsive disorder (2010)Drug treatment of obsessive-c…A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder (2010)A Single-Blinded Case-Control…A Double-Blind, Placebo-Controlled Trial of Lamotrigine for Pathological Skin Picking (2010)A Double-Blind, Placebo-Contr…Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder (2009)Memantine Augmentation in Tre…Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder (2008)Glutamatergic Synaptic Dysfun…N-Acetyl Cysteine in the Treatment of Grooming Disorders (2007)N-Acetyl Cysteine in the Trea…Association of the SLC1A1 glutamate transporter gene and obsessive‐compulsive disorder (2007)Association of the SLC1A1 glu…Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders (2006)Pharmacotherapy augmentation …THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)Development of a Rating Scale for Primary Depressive Illness (1967)Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): Initial Reliability and Validity Data (1997)Reduced functional connectivity within the limbic cortico‐striato‐thalamo‐cortical loop in unmedicated adults with obsessive‐compulsive disorder (2013)A family study of obsessive-compulsive disorder (1995)A Family Study of Obsessive-compulsive Disorder (2000)Diagnostic and Statistical Manual of Mental Disorders (2013)Repetitive transcranial magnetic stimulation (rTMS) for obsessive–compulsive disorder (OCD): An exploratory meta-analysis of randomized and sham-controlled trials (2013)Treatment of PANDAS and PANS: a systematic review (2018)The Yale-Brown Obsessive Compulsive Scale (1989)The Yale-Brown Obsessive Compulsive Scale (1989)The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency (1994)Association Testing of the Positional and Functional Candidate Gene SLC1A1/EAAC1 in Early-Onset Obsessive-compulsive Disorder (2006)Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder (2021)Obsessive-Compulsive Disorder in Children and Adolescents (1989)Symptom dimensions in obsessive–compulsive disorder: prediction of cognitive‐behavior therapy outcome (2005)Paroxetine treatment of compulsive hoarding (2006)Functional Neuroimaging in Obsessive-Compulsive Disorder (2011)Caudate Glucose Metabolic Rate Changes With Both Drug and Behavior Therapy for Obsessive-Compulsive Disorder (1992)The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers (2005)A Heuristic for Developing Transdiagnostic Models of Psychopathology (2011)Obsessive-compulsive disorder: beyond segregated cortico-striatal pathways (2011)Symptoms of obsessive-compulsive disorder (1997)Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections: Clinical Description of the First 50 Cases (1998)Use of Factor-Analyzed Symptom Dimensions to Predict Outcome With Serotonin Reuptake Inhibitors and Placebo in the Treatment of Obsessive-Compulsive Disorder (1999)Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive—compulsive disorder and major depression (2004)How effective are cognitive and behavioral treatments for obsessive–compulsive disorder? A clinical significance analysis (2005)Towards an international expert consensus for defining treatment response, remission, recovery and relapse in obsessive‐compulsive disorder (2016)Kaplan & Sadock's Comprehensive Textbook of Psychiatry (2000)Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome (2006)Current diagnosis and treatment of anxiety disorders. (2013)Diagnostic and Statistical Manual of Mental Disorders (2014)Tourette syndrome deep brain stimulation: A review and updated recommendations (2014)N-Acetyl Cysteine, a Glutamate-Modulating Agent, in the Treatment of Pathological Gambling: A Pilot Study (2007)The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder (2011)Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders (2019)Ten-Year Review of Rating Scales. II: Scales for Internalizing Disorders (2002)Invasive Circuitry-Based Neurotherapeutics: Stereotactic Ablation and Deep Brain Stimulation for OCD (2009)Brain circuitry of compulsivity (2015)Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma (2002)Emotion regulation in depression: Relation to cognitive inhibition (2009)Initial construction and validation of the Pathological Narcissism Inventory. (2009)
this work references cited by second hop

References

  • 1997Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet3,101 cited
  • 2000FUNCTIONAL NEUROIMAGING AND THE NEUROANATOMY OF OBSESSIVE-COMPULSIVE DISORDER840 cited
  • 2002Treatment non-response in OCD: methodological issues and operational definitions416 cited
  • 2000Decrease in Caudate Glutamatergic Concentrations in Pediatric Obsessive-Compulsive Disorder Patients Taking Paroxetine377 cited
  • 2005Glutamatergic Dysfunction in OCD344 cited
  • 2005Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial314 cited
  • 2003Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues300 cited
  • 2002Symptom Stability in Adult Obsessive-Compulsive Disorder: Data From a Naturalistic Two-Year Follow-Up Study279 cited
  • 2004Obsessive–Compulsive Disorder260 cited
  • 2004Reduced Anterior Cingulate Glutamatergic Concentrations in Childhood OCD and Major Depression Versus Healthy Controls246 cited
  • 2006Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder224 cited
  • 2004Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study202 cited

Cited by

  • 2007Association of the SLC1A1 glutamate transporter gene and obsessive‐compulsive disorder182 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2012Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder162 cited
  • 2020Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders161 cited
  • 2010A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder158 cited
  • 2012Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study152 cited
  • 2010Drug treatment of obsessive-compulsive disorder145 cited
  • 2011Neurobiology of obsessive–compulsive disorder: insights into neural circuitry dysfunction through mouse genetics143 cited
  • 2009Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder137 cited
  • 2008Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder125 cited
  • 2016N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial107 cited
  • 2006Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders102 cited
  • 2015N-Acetyl Cysteine in the Treatment of Obsessive Compulsive and Related Disorders: A Systematic Review96 cited
  • 2007N-Acetyl Cysteine in the Treatment of Grooming Disorders94 cited
  • 2013LONG-TERM OUTCOME IN ADULTS WITH OBSESSIVE-COMPULSIVE DISORDER94 cited
  • 2022Treatment-resistant OCD: Pharmacotherapies in adults87 cited
  • 2010A Double-Blind, Placebo-Controlled Trial of Lamotrigine for Pathological Skin Picking87 cited